The validation of anxiety rating scales in Parkinson's disease

The validation of anxiety rating scales in Parkinson's disease - Anxiety in Parkinson's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32820

Enrollment

Registered

2008-10-29

Start date

2009-01-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety parkinson's disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Idiopathic Parkinson's Disease according to the Queens Square Brain Bank criteria - Informed consent

Exclusion criteria

Exclusion criteria: - patients with neurodegenerative disorders other than PD - patients under 50 years of age - dementia or severe cognitive decline, operationalised as an Mini Mental State Exam score

Design outcomes

Primary

Measure	Time frame
The primary study parameters are the validity and reliability of the anxiety rating scales used resp; the Neuropsychiatric Invertory, anxiety section, the Hamilton Anxiety Rating Scale. the Clinical Global Impression Scale, the Beck Anxiety Inventory and the Hospital Anxiety and Depression Scale.	—

Secondary

Measure	Time frame
Secundary study parameters are: - prevalence rates of van anxiety disorders - atypical anxiety syndromes will be looked into by exploratory clusteranalysis of items on the various anxiety scales - anxiety states limited to 'off'periods and/or dyskinesia will be described by looking at score patterns across the additional questions pertaining to response fluctuations (see appendix protocol)	—

Countries

Netherlands

Outcome results